Result of General Meeting and Total Voting Rights
Eden Research plc announced that all resolutions at its General Meeting were passed, approving the Placing, Subscription, and Retail Offer. Directors Lykele van der Broek, Sean Smith, Alex Abrey, and Derek McAllan subscribed for new ordinary shares totaling 1,125,000, 500,000, 500,000, and 250,000 respectively, at 4 pence per share. Following admission on or around February 19, 2026, the company will have 613,362,994 ordinary shares in issue, with each carrying one vote.
Select text to share a quote on X · sign in to keep highlights & notes in your EDEN notes
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, announces that all resolutions put to Shareholders at the General Meeting held earlier today in connection with the Placing, Subscription and Retail Offer, as announced by the Company on 2 February 2026, were duly passed.
The total number of votes received by proxy on each resolution, as more fully disclosed in the Notice of General Meeting available on the Company's website, was as follows:
| Resolution | For | Against | Withheld | ||||
|---|---|---|---|---|---|---|---|
| Number of votes | % | Number of votes | % | Number of votes | % | ||
| 1 | To authorise the Directors to allot relevant securities for cash up to an aggregate nominal amount of £2,787,500, being equal to 278,750,000 New Ordinary Shares | 181,446,156 | 99.51% | 901,567 | 0.49% | 2,033,070 | - |
| 2 | To authorise the Directors to allot 278,750,000 New Ordinary Shares on a non-pre-emptive basis | 181,338,467 | 99.45% | 1,001,567 | 0.55% | 2,040,759 | - |
- A vote Withheld is not a vote in law and is not counted in the calculation of the votes cast For or Against the resolution, nor in the calculation of the percentage of issued share capital voted for any resolution.
- Votes For and Against are expressed as a percentage of votes validly cast for that resolution by proxy, excluding any Withheld votes.
Director Shareholdings
| Name | Number of existing Ordinary Shares | Number of Firm Shares subscribed for (1) | Number of Ordinary Shares held following Admission |
|---|---|---|---|
| Lykele van der Broek | 2,357,808 | 1,125,000 | 3,482,808 |
| Sean Smith | 3,059,768 | 500,000 | 3,559,768 |
| Alex Abrey | 3,181,678 | 500,000 | 3,681,678 |
| Derek McAllan | 843,627 | 250,000 | 1,093,627 |
Admission and Total Voting Rights
Following shareholder approval at the general meeting and conditional on First Admission, a total of 80,010,471 New Ordinary Shares (comprising 74,875,000 Firm Placing Shares, 1,375,000 Firm Subscription Shares and 3,760,471 Retail Offer Shares will be admitted to trading on AIM ("Admission") at 8.00 a.m. on or around 19 February 2026.
Following First Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 613,362,994 with each Ordinary Share carrying the right to one vote. There are no shares held in treasury and therefore, following Admission, the total number of voting rights in the Company will be 613,362,994.
Capitalised terms used in this announcement have the meaning given to them in the announcement dated 2 February 2026 and 6 February 2026, unless otherwise defined in this announcement.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | 1. Lykele van der Broek 2. Sean Smith 3. Alex Abrey 4. Derek McAllan | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | 1. Chairman 2. Chief Executive Officer 3. Chief Financial Officer 4. Non-Executive Director | ||||
| b) | Initial notification /Amendment | Initial notification | ||||
| a) | Name | Eden Research plc | ||||
| b) | LEI | 213800ZWTYTVQQSM3J85 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 1 pence each GB0001646941 | ||||
| b) | Nature of the transaction | 1 & 4: Subscription for New Ordinary Shares 2 & 3: Subscription for New Ordinary Shares through Placing | ||||
| c) | Price(s) and volume(s) |
pence 1,125,000 2 4 pence 500,000 3 4 pence 500,000 4 4 pence 250,000 | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 18 February 2026 | ||||
| f) | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.